PatternsRadar
Sign in

MANGALAMMangalam Drugs And Organics Limited

NSEASM Stage IBand 10%
27.55INR-1.01 (-3.54%)Close · 20 Nov 2026
5 Nov 2026Last results
HealthcareSector
Pharmaceuticals & BiotechnologyIndustry
₹44 CrMarket cap
—P/E (TTM)
72.7%Delivery

Filings & corporate actions

83 results filed
CSV
Next results · Q3 FY27
Expected 15 Jan 2027 – 14 Feb 2027
Estimate: filed 15–45 days after quarter end, last 5 times
Dividend
₹0.50 per share · last 21 Dec 2017
2026
  • 5 NovresultsResults · Q2 FY27 · consolidated and standalone-6.0%NSE
  • 15 OctshareholdingShareholding · 30 Sept 2026-2.5%NSE
  • 12 AugresultsResults · Q1 FY27 · consolidated and standalone+1.9%NSE
  • 10 JulshareholdingShareholding · 30 Jun 2026+1.8%NSE
  • 14 MayresultsResults · Q4 FY26 · consolidated and standalone-2.0%NSE
  • 17 AprshareholdingShareholding · 31 Mar 2026+0.5%NSE
  • 19 JanshareholdingShareholding · 31 Dec 2025+5.0%NSE
  • 15 JanresultsResults · Q3 FY26 · consolidated and standalone+5.0%NSE

Reaction to results · all yearsrose on day 0 in 30 of 79 CSV

QuarterFiledDay 0+5D+20DRel vol
Q2 FY275 Nov 2026-6.0%-4.6%—1.8×
Q1 FY2712 Aug 2026+1.9%-1.2%+27.9%2.6×
Q4 FY2614 May 2026-2.0%-3.7%-3.2%0.8×
Q3 FY2615 Jan 2026+5.0%-0.8%-27.0%1.1×
Q2 FY2620 Nov 2025-4.0%-42.2%-50.3%3.5×
Q1 FY2619 Aug 2025+0.9%-3.4%-7.7%0.2×
Q4 FY2518 May 2025-3.2%-0.2%-1.9%5.4×
Q3 FY2514 Feb 2025-4.4%-7.5%-26.2%0.7×
Q2 FY2515 Nov 2024+1.0%+1.0%+14.5%0.8×
Q1 FY2514 Aug 2024-1.4%+17.8%+19.5%0.5×
Q4 FY2422 May 2024-3.8%-14.2%-10.0%9.4×
Q3 FY2414 Feb 2024+2.1%+9.1%-12.1%1.1×
Q2 FY249 Nov 2023-0.1%-0.6%+0.1%0.2×
Q1 FY2411 Aug 2023-2.9%-4.8%-1.6%1.6×
Q4 FY2331 May 2023-0.9%+0.4%+3.2%0.9×
Q3 FY2314 Feb 2023+1.6%-1.7%+2.3%0.4×
Q2 FY2311 Nov 2022-3.0%-5.5%-0.8%1.1×
Q1 FY236 Aug 2022-2.6%-7.3%-3.8%3.1×
Q4 FY2227 May 2022+7.5%+31.1%+24.6%5.0×
Q3 FY225 Feb 2022-2.1%-10.4%-16.2%0.5×
Q2 FY2213 Nov 2021-5.0%-7.2%-10.9%2.4×
Q1 FY2213 Aug 2021-1.7%-7.4%+0.7%0.4×
Q4 FY2121 May 2021-8.9%-10.4%-1.7%1.4×
Q3 FY2112 Feb 2021-7.2%-18.6%-19.0%4.2×
Q2 FY2113 Nov 2020+5.0%-2.4%-6.5%4.7×
Q1 FY2111 Aug 2020+5.0%+33.9%+52.6%0.7×
Q4 FY2030 Jun 2020-0.3%-10.7%-13.2%1.5×
Q3 FY2024 Jan 2020+4.9%-6.9%-13.7%4.2×
Q2 FY202 Nov 2019+4.9%-8.6%-19.9%0.7×
Q1 FY2027 Jul 2019+4.9%-4.3%-10.6%1.7×
Q4 FY1910 May 2019-3.3%-5.8%-19.8%1.2×
Q3 FY1919 Feb 2019+2.1%+12.9%+41.4%0.5×
Q2 FY1927 Nov 2018-1.9%-4.9%-2.9%0.6×
Q1 FY1931 Aug 2018+1.2%+0.8%-17.1%0.5×
Q4 FY1822 Jun 2018-0.6%-6.6%-24.7%0.3×
Q3 FY1823 Feb 2018+1.7%-3.4%+2.0%1.7×
Q2 FY1823 Nov 2017-1.8%-1.3%+10.1%0.9×
Q1 FY185 Sept 2017-1.1%-1.3%+7.3%0.6×
Q4 FY1730 May 2017+0.4%-1.1%-8.4%1.3×
Q3 FY178 Feb 2017+0.3%-4.1%-3.5%0.7×
Q2 FY1714 Nov 2016-13.5%-19.7%-9.5%1.8×
Q1 FY173 Aug 2016+0.4%+0.9%+0.5%0.3×
Q4 FY1619 May 2016-4.0%-9.2%-23.1%1.5×
Q3 FY1618 Jan 2016-5.0%-10.2%-42.3%0.0×
Q2 FY1623 Oct 2015+1.5%-5.4%+52.9%1.0×
Q1 FY166 Aug 2015-5.0%-0.3%-4.6%1.4×
Q4 FY1521 May 2015-0.2%-8.4%+41.3%0.5×
Q3 FY1528 Jan 2015-6.4%-9.2%-14.7%0.9×
Q2 FY1515 Dec 2014-2.2%+2.2%-3.6%0.4×
Q1 FY1519 Aug 2014+4.9%+18.8%+52.8%3.8×
Q4 FY143 Jun 2014+4.5%+24.5%+62.7%0.0×
Q3 FY1417 Feb 2014-3.7%-21.5%-41.5%0.8×
Q2 FY1425 Nov 2013-4.8%+4.8%+42.9%0.5×
Q1 FY1419 Aug 2013-4.8%-14.3%-29.5%0.0×
Q4 FY1327 May 2013-5.0%-17.4%-36.4%0.0×
Q3 FY131 Mar 2013+4.8%-0.8%-12.7%0.4×
Q2 FY1320 Nov 2012-5.4%-20.8%-16.8%0.1×
Q1 FY133 Aug 2012-6.7%0.0%-22.2%0.6×
Q4 FY1222 May 2012+1.8%+11.4%-15.0%1.2×
Q3 FY1213 Feb 2012-1.2%-3.1%-12.2%0.4×
Q2 FY1211 Nov 2011+0.4%-3.2%-9.7%0.6×
Q1 FY1226 Aug 2011+3.6%+3.6%+9.9%0.2×
Q4 FY114 Jun 20110.0%+0.8%-3.4%0.5×
Q3 FY1110 Feb 2011-0.5%+10.8%+15.0%2.4×
Q2 FY1112 Nov 2010-1.2%-4.3%-22.5%0.5×
Q1 FY1129 Jul 2010-1.5%-1.5%-5.1%0.1×
Q4 FY101 Jun 2010+1.1%+1.5%+0.7%0.5×
Q3 FY1029 Jan 2010-5.0%+0.7%-6.0%0.6×
Q2 FY1028 Oct 2009+1.7%-7.8%-2.2%0.4×
Q1 FY101 Aug 2009+5.4%+1.8%+33.9%1.8×
Q4 FY0918 Jun 2009+2.3%+3.4%-17.2%0.6×
Q3 FY0929 Jan 2009-0.8%-10.0%-11.7%0.5×
Q2 FY0924 Oct 20080.0%-3.5%-25.0%1.3×
Q1 FY0931 Jul 2008-0.8%+4.0%+22.8%0.4×
Q4 FY0820 Jun 2008-3.0%-10.9%-9.4%0.2×
Q3 FY0831 Jan 2008-4.1%+0.6%-9.5%0.1×
Q2 FY082 Nov 2007-1.6%-4.5%+8.4%0.5×
Q1 FY088 Aug 20070.0%-0.3%+9.7%0.5×
Q4 FY0729 Jun 2007+0.6%-3.8%+4.1%0.7×
Average-0.9%-2.6%-2.2%

Close-to-close from the session before the filing could trade. Day 0 is the first session after it.

Growth · Q2 FY27

Revenue YoY+60.2%
Profit YoY—
Interest cost YoY-11.4%
Revenue QoQ+39.0%
Profit QoQ—
CAGR2Y3Y4Y5Y6Y7Y
Revenue-14.2%—————
Profit——————

Key data

Open28.90
Day range26.80 – 29.00
52-week range22.80 – 62.50
From 52w high-55.9%
RSI (14)38.3
ATR (14)1.56
Volume41.2K
Avg volume (20D)18.8K
Rel volume2.20×
Volatility (1Y)56.2%
Turnover₹11.4L
Traded value (NSE)₹11.4L
VWAP27.53
SMA 50 / 20030.66 / 29.91
Price band10%

Delivery percentage

Latest · 20 Nov 202672.7%
20-day avg75.8%
1-year avg82.0%
Percentile (own history)74th
Range2.5–100.0%
Sessions3,185

Over the last 20 sessions MANGALAM settled 75.8% of its traded quantity, which is unusually high for an NSE equity. Its one-year average is 82.0%, so recent sessions are running 6.2 points lower than usual. The latest session ranks higher than 74% of the 3,185 sessions on record for it.

What delivery percentage measuresScan the whole market on delivery

Dividends, deals & holders

Dividend yield0.00%
Dividend, trailing 12M₹0.00
Paid every year for0 yr
Shareholders24.0K · -1.9% QoQ
Net bulk deals, 30D0.00%
Block deals, 30D₹0
Last bulk buy291 days ago

Performance returns

1D1W1M3M6M1Y
Price-3.54%-5.75%-6.83%+2.23%-9.70%-55.78%

Valuation

Market cap₹44 Cr
Market cap (NSE)₹44 Cr
Free-float cap₹28 Cr
P/E (TTM)—
P/E (NSE)—
EPS (TTM)-24.07
P/B0.5
Net margin (TTM)-14.5%
Other income / PBT—
ROE-35.4%
Debt / equity1.00
Shares outstanding1.58Cr
Listed23 May 2005

Ownership

Promoter35.65%
Promoter Δ QoQ0.00 pp
Public64.35%
FII0.11%
DII0.00%
Pledged0.00%

Quarterly results · consolidated

Q3 FY26Q4 FY26Q1 FY27Q2 FY27
Revenue (₹ Cr)58.567.357.179.4
YoY chg-34.1%-7.9%-0.4%+60.2%
Net profit (₹ Cr)(9.8)(13.4)(7.6)(7.2)
YoY chg-864.3%-22692.6%——
Net margin-16.8%-19.9%-13.4%-9.1%
EPS-6.21-8.48-4.83-4.55

Shareholding over time

By quarter

30 Sept 2026 · promoter 35.65% · public 64.35%
30 Sept 2021: promoter 50.53%31 Dec 2021: promoter 50.53%31 Mar 2022: promoter 50.53%30 Jun 2022: promoter 50.42%30 Sept 2022: promoter 50.42%31 Dec 2022: promoter 50.32%31 Mar 2023: promoter 50.32%30 Jun 2023: promoter 50.32%30 Sept 2023: promoter 50.32%31 Dec 2023: promoter 50.32%31 Mar 2024: promoter 50.32%30 Jun 2024: promoter 50.32%30 Sept 2024: promoter 50.30%31 Dec 2024: promoter 50.30%31 Mar 2025: promoter 50.30%30 Jun 2025: promoter 50.30%30 Sept 2025: promoter 50.30%31 Dec 2025: promoter 35.64%31 Mar 2026: promoter 35.65%30 Jun 2026: promoter 35.65%30 Sept 2026: promoter 35.65%
2021-092026-09
  • Promoter
  • Public and others
Promoter
35.65%
Public
64.35%
Promoter change
0.00 pp
Filed
15 Oct 2026
FII
0.11%
DII
0.00%
Promoter pledged
0.00%

Who the public is

Mutual funds
0.00%

0.00 pp QoQ

Insurance
0.00%

0.00 pp QoQ

FPI
0.11%

0.00 pp QoQ

Retail ≤ ₹2L
50.02%

-0.17 pp QoQ

HNI > ₹2L
10.48%

+0.16 pp QoQ

NRI
1.31%

+0.06 pp QoQ

Bodies corporate
0.78%

-0.07 pp QoQ

Shareholders
23,991

-1.9% QoQ

Major holders

As of 30 Sept 2026
HolderTypeHolding
Shree Rasbihari Trading & Investment Pvt LtdPromoter · Corporate6.21%
Shri Jb Pharma Private LimitedPromoter · Corporate6.00%
Govardhan Murlidhar DhootPromoter · Individual3.23%
Shree Kishoriju Trading & Investment Pvt LtdPromoter · Corporate3.21%
Brijmohan Murlidhar DhootPromoter · Individual3.08%
Shweta Govardhan DhootPromoter · Individual2.59%
Radhika Ajay DhootPromoter · Individual1.85%
Smita Aditya DhootPromoter · Individual1.85%
Ramniwas Ramdayal DhootPromoter · Individual1.74%
Anish DwivediIndividual1.42%

Every promoter-group member, and each public holder above 1%, as filed.

Promoter and public shares of total equity, from the pattern filed each quarter. Institutional, pledge and public-breakdown figures come from the filing's XBRL, which most filings before Sep-2021 lack, so they are absent there rather than zero. Changes are against the previous filing.

Dividends

since 21 Dec 2017 CSV
Financial yearPaymentsDeclaredAdjusted
FY2017-181₹0.50₹0.50
Ex-dateRecord dateDeclaredAdjusted
21 Dec 2017—₹0.50₹0.50

Rupees per share by ex-date, from NSE’s corporate actions; the record date is who was paid. Declared is the figure in the filing; adjusted restates it for splits and bonuses since, on the same basis as the price chart. Financial years run April to March.

Price-band hits

Loading…

Sessions the stock closed at the limit of its daily price band, from NSE's end-of-day list. A stock pinned at the band could not trade past it that day.

Insider trades

Insiders net, 30d
₹0
Insiders net, 90d
₹0
Promoters net, 90d
₹0
Insider buyers, 90d
0
Last promoter buy
none on record
Disclosures on record
158
2 open-market of the newest 100
By year
BroadcastPersonSideSharesValuePriceHolding before → afterStakeRegulation
8 Jun 2022Shweta G. DhootPromoterSell9.0K₹12.8L142.4719.0K → 10.0K0.06%-0.05 pp7(2)told 6 Jun 2022
8 Jun 2022Chandrkanta M. DhootPromoterSell9.0K₹12.6L139.544.30L → 4.21L2.66%-0.06 pp7(2)told 6 Jun 2022

SEBI insider-trading disclosures, equity only. Dated by the day NSE broadcast them; the trade itself is often weeks earlier. The figures count promoters, directors and KMPs buying or selling on the exchange — not ESOPs, gifts, transfers within the promoter group or pledges. Stake is the holding after, as filed; the change beneath it scales that by the share counts before and after. Regulation is the PIT clause cited, and “told” the day the insider informed the company.

How the insider figures are countedPromoters buying in the open market, market-wideEvery stock on this session

Bulk & block deals · 3 Feb 2026

CSV
12 of 183 deals
By year
DateDealClientQuantityPriceValue
3 Feb 2026Sell · bulkNEO APEX VENTURE LLP3.50L37.90₹1.3Cr
2 Feb 2026Buy · bulkNEO APEX VENTURE LLP4.56L32.68₹1.5Cr
13 Jan 2026Sell · bulkJYOTIPRASAD TAPARIA1.50L42.64₹64.0L
13 Jan 2026Sell · bulkSANJAY KUMAR SAINI95.0K40.65₹38.6L
12 Jan 2026Sell · bulkASHUTOSH TAPARIA2.00L40.61₹81.2L
12 Jan 2026Sell · bulkSHIVKUMAR DAMANI82.0K40.61₹33.3L
8 Jan 2026Buy · bulkEPITOME TRADING AND INVESTMENTS1.00L36.84₹36.8L
7 Jan 2026Sell · bulkKEDIA SECURITIES PRIVATE LIMITED1.38L35.09₹48.4L
7 Jan 2026Sell · bulkMULTIPLIER SHARE & STOCK ADVISORS PRIVATE LIMITED1.25L34.90₹43.6L
7 Jan 2026Sell · bulkEPITOME TRADING AND INVESTMENTS1.20L34.90₹41.9L
7 Jan 2026Sell · bulkSHARE INDIA SECURITIES LIMITED1.00L34.40₹34.4L
7 Jan 2026Buy · bulkBONANZA PORTFOLIO LTD80.0K34.90₹27.9L

A bulk deal is a client trading over 0.5% of the company’s shares in a day; a block deal is one large trade in the separate block window. Quantities and prices are as NSE published them, not split-adjusted.

Every stock on this session →

Takeover-code disclosures

Loading…

Filed under SEBI’s takeover regulations when a holding crosses 5% of the company, and again with every 2% it moves after that. Shares and percentages as filed.

Every stock on this session →

Short selling, lending & margin

Loading…

Shares bought on broker margin funding (MTF) and still held at the day’s end, and the amount brokers have lent against them.

Exchange surveillance

20 Nov 2026
  • Long-term ASM · Stage I · since 11 Sept 2026 — Long-term Additional Surveillance Measure: after a sustained unusual move, trades carry a higher margin and, at later stages, settle trade-for-trade.
  • Under 100 traders in 30 days · since 9 Nov 2026 — Fewer than 100 distinct investors traded it in the last 30 days.
  • Zero EPS (4 quarters) · since 28 Apr 2026 — Zero EPS over the last four quarters.

Price band: 10% · not in the F&O ban.

From NSE’s daily surveillance, price-band and position-limit files. A stock enters the F&O ban when open interest passes 95% of its market-wide position limit and leaves it below 80%; until then no new positions can be opened. CSV: measures · band changes.

Every stock on this session →

Financials · quarterly statement

₹ crore, as filed
By year
 Q3 FY24Q4 FY24AQ1 FY25Q2 FY25Q3 FY25Q4 FY25AQ1 FY26Q2 FY26RQ3 FY26Q4 FY26AQ1 FY27Q2 FY27
Revenue from operations97.3102.276.579.988.773.057.349.558.567.357.179.4
Other income0.00.00.00.10.10.20.00.00.10.10.10.2
Total income97.3102.376.680.188.873.257.349.658.667.457.279.6
Total expenses97.398.476.078.987.571.670.362.068.480.664.088.6
└ Finance costs3.34.03.73.73.54.04.05.04.13.13.73.9
└ Depreciation3.63.93.94.04.04.74.54.64.54.74.14.1
Profit before tax0.03.90.61.21.41.6(13.0)(12.5)(9.8)(13.3)(6.7)(9.0)
Tax expense(0.5)0.4(2.1)(1.5)0.11.60.8(5.1)0.00.10.9(1.8)
Net profit0.53.52.72.71.30.1(13.8)(7.3)(9.8)(13.4)(7.6)(7.2)
EPS0.312.231.701.700.810.04-8.72-4.64-6.21-8.48-4.83-4.55
Net margin0.51%3.45%3.51%3.36%1.45%0.08%-24.06%-14.83%-16.82%-19.94%-13.37%-9.08%
PBT margin0.04%3.84%0.76%1.50%1.54%2.24%-22.67%-25.16%-16.82%-19.72%-11.81%-11.32%
Tax rate-1091.15%10.14%-359.22%-124.18%5.85%96.37%——————

A audited · R restated by a later filing · negatives in parentheses. EPS and the share count are restated onto the same split-adjusted basis as the price chart, so they can be read against it; every rupee figure is exactly as filed. The balance sheet and cash flow arrive only with the half-year and annual filings, and are in their own section below. Latest filed 5 Nov 2026.

Balance sheet & cash flow · half-yearly

₹ crore, as filed
By year

Balance sheet

 H1 FY24FY24H1 FY25FY25H1 FY26FY26H1 FY27
Total assets380.7333.4364.1366.4316.7315.0298.3
Current assets228.2175.7201.0199.0152.8155.7145.8
└ Cash & equivalents5.70.96.12.63.40.70.8
└ Other bank balances0.00.00.00.00.00.00.0
└ Current investments0.00.00.00.00.00.00.0
└ Trade receivables29.027.925.639.117.040.332.9
└ Inventories140.5123.6143.0138.8116.9102.896.3
Total equity132.4135.8148.0149.0127.6103.187.9
└ Attributable to owners132.4135.8148.0149.0127.6103.187.9
└ Non-controlling interest0.0—0.00.0—0.00.0
└ Share capital15.815.815.815.815.815.815.8
Borrowings75.587.974.781.289.1105.588.0
└ Current57.774.665.571.977.896.982.8
└ Non-current17.813.49.29.211.38.65.2
Trade payables104.765.991.791.168.675.976.8
Current liabilities209.1163.8192.4191.6168.7196.6198.0
Total liabilities248.3197.6216.1217.4189.1211.9210.3
Net debt69.887.068.678.685.7104.887.2
Debt / equity0.570.650.510.540.701.021.00
Current ratio1.091.071.041.040.910.790.74

Cash flow, year to date

 H1 FY24FY24H1 FY25FY25H1 FY26FY26H1 FY27
Operating cash flow(15.0)(11.1)31.942.67.74.223.4
└ Capex0.00.0(6.7)(20.2)(5.8)(11.9)(1.8)
Free cash flow(15.0)(11.1)25.322.41.9(7.7)21.6
Investing cash flow0.00.0(6.4)(19.5)(5.8)(11.7)(1.7)
Financing cash flow0.00.0(20.6)(21.7)(1.2)5.7(21.6)
└ Dividends paid0.00.00.00.00.00.00.0
└ Buybacks0.00.00.00.00.00.00.0
Net change in cash(15.0)(11.1)4.91.40.8(1.9)0.1

From the half-year and annual results filings: the balance sheet from September 2022, the cash flow from September 2020. Those are when NSE’s XBRL began to carry each statement; earlier filings have it only in the attached PDF. Cash flow columns are year to date, so an H1 column covers April to September and an FY column the full year. Outflows are in parentheses. Net debt is borrowings less cash, bank balances and current investments; for banks, NBFCs and insurers it, debt to equity and the current ratio are left blank because their statements are not built that way.

Announcements & board meetings

Loading…

As the company filed them with NSE, newest first. Board meetings are dated by the meeting, which is usually a week or more after the intimation.

Every stock on this session →

MANGALAM at a glance

  • MANGALAM closed at ₹27.55 on 20 Nov 2026, -3.54% on the day, -55.8% over one year, 55.9% below its 52-week high of ₹62.5.
  • Delivery was 72.7% of traded quantity on 20 Nov 2026, the 74th percentile of its own 3,185 sessions with a reading (20-session average 75.8%, 1-year average 82.0%).
  • Market capitalisation is ₹44 crore, with no positive trailing earnings for a P/E (trailing EPS ₹-24.07).
  • Q2 FY27 results (consolidated, filed 5 Nov 2026): revenue ₹79 crore (+60.2% year on year), net profit ₹-7 crore; the price moved -6.0% on the first session after.
  • Promoters held 35.65% at 30 Sept 2026, unchanged on the previous filing.
  • Q3 FY27 results are expected between 15 Jan 2027 and 14 Feb 2027, going by past filing dates — an estimate, not an announcement.

About

Macro sectorHealthcare
Basic industryPharmaceuticals
ISININE584F01014
SeriesEQ
Listed23 May 2005
NSE market cap · 17 Nov 2026₹46 Cr
Free-float market cap (NSE)₹30 Cr
Shares outstanding (NSE)1.58Cr
History from23 May 2005
Sessions5,126

Prices are adjusted for splits and bonuses. Delivery figures come from NSE’s daily reports and are unavailable for older sessions. Sourced from the eod2 dataset, last updated 20 Nov 2026.